Forrest, Alan

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy

Antibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance

Cited by 1,101

Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore

Ambrose, P. G., Bhavnani, S. M., Rubino, C. M., Louie, A., Gumbo, T., Forrest, A., & Drusano, G. L. (2007) · Clinical Infectious Diseases

Antibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance

Cited by 697

Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme.

Rayner, C. R., Forrest, A., Meagher, A. K., Birmingham, M. C., & Schentag, J. J. (2003) · Clinical Pharmacokinetics

Antibiotics Pharmacokinetics and EfficacyNeutropenia and Cancer Infections

Cited by 306

Dosing guidance for intravenous colistin in critically-ill patients.

Nation, R. L., Garonzik, S. M., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Forrest, A., Paterson, D. L., Li, J., & Silveira, F. P. (2017) · Clinical Infectious Diseases

Antibiotics Pharmacokinetics and EfficacyAntibiotic Resistance in Bacteria

Cited by 262

Pharmacokinetics-Pharmacodynamics of Tigecycline in Patients with Community-Acquired Pneumonia

Rubino, C. M., Bhavnani, S. M., Forrest, A., Dukart, G., Dartois, N., Cooper, A., Korth-Bradley, J., & Ambrose, P. G. (2012) · Antimicrobial Agents and Chemotherapy

Antibiotics Pharmacokinetics and EfficacyPneumonia and Respiratory Infections

Cited by 54

Attenuated Vancomycin Bactericidal Activity against Staphylococcus aureus hemB Mutants Expressing the Small-Colony-Variant Phenotype

Tsuji, B. T., von Eiff, C., Kelchlin, P. A., Forrest, A., & Smith, P. F. (2008) · Antimicrobial Agents and Chemotherapy

Antimicrobial Resistance in StaphylococcusBacterial Genetics and Biotechnology

Cited by 51